,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m,ticker
0,D,2022-02-28 19:18:38,2022-02-28,LXRX,Alexander Kristen,"VP, Finance, Accounting",F - Tax,$2.85,-3337,16963,-16%,"-$9,510",,,,,LXRX
1,D,2022-02-28 19:18:38,2022-02-28,LXRX,Alexander Kristen,"VP, Finance, Accounting",M - OptEx,$0.00,11300,16963,+200%,+$0,,,,,LXRX
2,D,2022-02-28 19:17:06,2022-02-28,LXRX,Seth Kiernan,"VP, Chief Commercial Officer",F - Tax,$2.85,-8261,21867,-27%,"-$23,544",,,,,LXRX
3,D,2022-02-28 19:17:06,2022-02-28,LXRX,Seth Kiernan,"VP, Chief Commercial Officer",M - OptEx,$0.00,30128,21867,-365%,+$0,,,,,LXRX
4,D,2022-02-28 19:16:06,2022-02-28,LXRX,Main Alan J,"EVP, Innov, Chem Sciences",F - Tax,$2.85,-19756,175589,-10%,"-$56,305",,,,,LXRX
5,D,2022-02-28 19:16:06,2022-02-28,LXRX,Main Alan J,"EVP, Innov, Chem Sciences",M - OptEx,$0.00,54650,175589,+45%,+$0,,,,,LXRX
6,D,2022-02-28 19:15:07,2022-02-28,LXRX,Kassler-Taub Kenneth B.,"SVP, Regulatory, QA",F - Tax,$2.85,-13241,85857,-13%,"-$37,737",,,,,LXRX
7,D,2022-02-28 19:15:07,2022-02-28,LXRX,Kassler-Taub Kenneth B.,"SVP, Regulatory, QA",M - OptEx,$0.00,36628,85857,+74%,+$0,,,,,LXRX
8,D,2022-02-28 19:13:52,2022-02-28,LXRX,Crum Brian T,"SVP, GC, Secr.",F - Tax,$2.85,-15059,99458,-13%,"-$42,918",,,,,LXRX
9,D,2022-02-28 19:13:52,2022-02-28,LXRX,Crum Brian T,"SVP, GC, Secr.",M - OptEx,$0.00,40880,99458,+70%,+$0,,,,,LXRX
10,D,2022-02-28 19:12:06,2022-02-28,LXRX,Wade Jeffrey L,"Pres, CFO",F - Tax,$2.85,-25773,193680,-12%,"-$73,453",,,,,LXRX
11,D,2022-02-28 19:12:06,2022-02-28,LXRX,Wade Jeffrey L,"Pres, CFO",M - OptEx,$0.00,66933,193680,+53%,+$0,,,,,LXRX
12,D,2022-02-28 19:11:15,2022-02-28,LXRX,Coats Lonnel,CEO,F - Tax,$2.85,-48053,586003,-8%,"-$136,951",,,,,LXRX
13,D,2022-02-28 19:11:15,2022-02-28,LXRX,Coats Lonnel,CEO,M - OptEx,$0.00,197343,586003,+51%,+$0,,,,,LXRX
14,D,2021-04-27 16:51:35,2021-04-24,LXRX,Swain Judith L,Dir,M - OptEx,$0.00,10638,27006,+65%,+$0,,,,,LXRX
15,D,2021-04-27 16:50:42,2021-04-24,LXRX,Sobecki Christopher J,Dir,M - OptEx,$0.00,10638,151397,+8%,+$0,,,,,LXRX
16,D,2021-04-27 16:49:50,2021-04-24,LXRX,Palantoni Frank,Dir,M - OptEx,$0.00,10638,27006,+65%,+$0,,,,,LXRX
17,D,2021-04-27 16:48:58,2021-04-24,LXRX,Nies Alan S,Dir,M - OptEx,$0.00,10638,27720,+62%,+$0,,,,,LXRX
18,D,2021-04-27 16:48:16,2021-04-24,LXRX,Lefkowitz Robert J Md,Dir,M - OptEx,$0.00,10638,27006,+65%,+$0,,,,,LXRX
19,D,2021-04-27 16:47:16,2021-04-24,LXRX,Debbane Raymond,Dir,M - OptEx,$0.00,10638,4648735,0%,+$0,,,,,LXRX
20,D,2021-04-27 16:46:36,2021-04-24,LXRX,Barker Sam L,Dir,M - OptEx,$0.00,10638,66291,+19%,+$0,,,,,LXRX
21,D,2021-04-27 16:45:32,2021-04-24,LXRX,Amouyal Philippe,Dir,M - OptEx,$0.00,10638,27006,+65%,+$0,,,,,LXRX
22,D,2021-03-16 19:45:56,2021-03-15,LXRX,Tessmer James F,"VP, Finance, Accounting",M - OptEx,$3.31,12000,71766,+20%,"+$39,720",,,,,LXRX
23,D,2021-03-16 19:45:56,2021-03-15,LXRX,Tessmer James F,"VP, Finance, Accounting",S - Sale+OE,$6.92,-22912,71766,-24%,"-$158,440",,,,,LXRX
24,D,2021-03-02 17:01:47,2021-02-28,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",F - Tax,$7.19,-26584,157020,-14%,"-$191,139",,,,,LXRX
25,D,2021-03-02 17:01:47,2021-02-28,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",M - OptEx,$0.00,68109,157020,+77%,+$0,,,,,LXRX
26,D,2021-03-02 17:00:45,2021-02-28,LXRX,Tyle Praveen,"EVP, R, D",F - Tax,$7.19,-16560,120791,-12%,"-$119,066",,,,,LXRX
27,D,2021-03-02 17:00:45,2021-02-28,LXRX,Tyle Praveen,"EVP, R, D",M - OptEx,$0.00,68007,120791,+129%,+$0,,,,,LXRX
28,D,2021-03-02 17:00:02,2021-02-28,LXRX,Tessmer James F,"VP, Finance, Accounting",F - Tax,$7.19,-10765,82678,-12%,"-$77,400",,,,,LXRX
29,D,2021-03-02 17:00:02,2021-02-28,LXRX,Tessmer James F,"VP, Finance, Accounting",M - OptEx,$0.00,28316,82678,+52%,+$0,,,,,LXRX
30,D,2021-03-02 16:59:03,2021-02-28,LXRX,Main Alan J,"EVP, Innov, Chem Sciences",F - Tax,$7.19,-20413,140695,-13%,"-$146,769",,,,,LXRX
31,D,2021-03-02 16:59:03,2021-02-28,LXRX,Main Alan J,"EVP, Innov, Chem Sciences",M - OptEx,$0.00,56468,140695,+67%,+$0,,,,,LXRX
32,D,2021-03-02 16:57:59,2021-02-28,LXRX,Crum Brian T,"VP, GC, Secr.",F - Tax,$7.19,-14860,73637,-17%,"-$106,843",,,,,LXRX
33,D,2021-03-02 16:57:59,2021-02-28,LXRX,Crum Brian T,"VP, GC, Secr.",M - OptEx,$0.00,38765,73637,+111%,+$0,,,,,LXRX
34,D,2021-03-02 16:57:05,2021-02-28,LXRX,Coats Lonnel,"Pres, CEO",F - Tax,$7.19,-55038,436713,-11%,"-$395,723",,,,,LXRX
35,D,2021-03-02 16:57:05,2021-02-28,LXRX,Coats Lonnel,"Pres, CEO",M - OptEx,$0.00,192885,436713,+79%,+$0,,,,,LXRX
36,,2020-12-17 14:43:18,2020-12-16,LXRX,Artal International S.C.A.,"Dir, 10%",P - Purchase,$3.20,10937500,71178364,+18%,"+$35,000,000",,,,,LXRX
37,,2020-12-17 14:39:27,2020-12-16,LXRX,"Invus Public Equities, L.P.","Dir, 10%",P - Purchase,$3.20,10937500,71178364,+18%,"+$35,000,000",,,,,LXRX
38,D,2020-04-27 16:49:41,2020-04-26,LXRX,Swain Judith L,Dir,M - OptEx,$0.00,3466,16368,+27%,+$0,,,,,LXRX
39,D,2020-04-27 16:48:56,2020-04-26,LXRX,Sobecki Christopher J,Dir,M - OptEx,$0.00,3466,140759,+3%,+$0,,,,,LXRX
40,D,2020-04-27 16:48:08,2020-04-26,LXRX,Palantoni Frank,Dir,M - OptEx,$0.00,3466,16368,+27%,+$0,,,,,LXRX
41,D,2020-04-27 16:47:23,2020-04-26,LXRX,Nies Alan S,Dir,M - OptEx,$0.00,3466,17082,+25%,+$0,,,,,LXRX
42,D,2020-04-27 16:46:36,2020-04-26,LXRX,Lefkowitz Robert J Md,Dir,M - OptEx,$0.00,3466,16368,+27%,+$0,,,,,LXRX
43,D,2020-04-27 16:45:43,2020-04-26,LXRX,Debbane Raymond,Dir,M - OptEx,$0.00,3466,4638097,0%,+$0,,,,,LXRX
44,D,2020-04-27 16:44:44,2020-04-26,LXRX,Barker Sam L,Dir,M - OptEx,$0.00,3466,55653,+7%,+$0,,,,,LXRX
45,D,2020-04-27 16:43:59,2020-04-26,LXRX,Amouyal Philippe,Dir,M - OptEx,$0.00,3466,16368,+27%,+$0,,,,,LXRX
46,,2020-04-24 17:24:31,2020-04-22,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",A - Grant,$0.00,26525,115495,+30%,+$0,,,,,LXRX
47,,2020-04-24 17:24:31,2020-04-22,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",F - Tax,$1.96,-9651,115495,-8%,"-$18,916",,,,,LXRX
48,,2020-04-24 17:20:28,2020-04-22,LXRX,Tyle Praveen,"EVP, R, D",A - Grant,$0.00,19893,69344,+40%,+$0,,,,,LXRX
49,,2020-04-24 17:20:28,2020-04-22,LXRX,Tyle Praveen,"EVP, R, D",F - Tax,$1.96,-4844,69344,-7%,"-$9,494",,,,,LXRX
50,,2020-04-24 17:15:45,2020-04-22,LXRX,Tessmer James F,"VP, Finance, Accounting",A - Grant,$0.00,13262,65127,+26%,+$0,,,,,LXRX
51,,2020-04-24 17:15:45,2020-04-22,LXRX,Tessmer James F,"VP, Finance, Accounting",F - Tax,$1.96,-3997,65127,-6%,"-$7,834",,,,,LXRX
52,,2020-04-24 17:12:22,2020-04-22,LXRX,Santini Alexander A,"EVP, CCO",A - Grant,$0.00,19893,55584,+56%,+$0,,,,,LXRX
53,,2020-04-24 17:12:22,2020-04-22,LXRX,Santini Alexander A,"EVP, CCO",F - Tax,$1.96,-6813,55584,-11%,"-$13,353",,,,,LXRX
54,,2020-04-24 17:08:54,2020-04-22,LXRX,Main Alan J,"EVP, Commercial Supply Ops",A - Grant,$0.00,19893,104640,+23%,+$0,,,,,LXRX
55,,2020-04-24 17:08:54,2020-04-22,LXRX,Main Alan J,"EVP, Commercial Supply Ops",F - Tax,$1.96,-6813,104640,-6%,"-$13,353",,,,,LXRX
56,,2020-04-24 17:05:21,2020-04-22,LXRX,Crum Brian T,"VP, GC, Secr.",A - Grant,$0.00,19893,49732,+67%,+$0,,,,,LXRX
57,,2020-04-24 17:05:21,2020-04-22,LXRX,Crum Brian T,"VP, GC, Secr.",F - Tax,$1.96,-6398,49732,-11%,"-$12,540",,,,,LXRX
58,,2020-04-24 17:02:57,2020-04-22,LXRX,Lapuerta Pablo,"EVP, CMO",A - Grant,$0.00,19893,85719,+30%,+$0,,,,,LXRX
59,,2020-04-24 17:02:57,2020-04-22,LXRX,Lapuerta Pablo,"EVP, CMO",F - Tax,$1.96,-6813,85719,-7%,"-$13,353",,,,,LXRX
60,D,2020-03-03 16:18:35,2020-02-28,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",F - Tax,$2.77,-16025,98621,-14%,"-$44,389",,,,,LXRX
61,D,2020-03-03 16:18:35,2020-02-28,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",M - OptEx,$0.00,42138,98621,+75%,+$0,,,,,LXRX
62,D,2020-03-03 16:17:53,2020-02-28,LXRX,Tyle Praveen,"EVP, R, D",M - OptEx,$0.00,39316,54295,+262%,+$0,,,,,LXRX
63,D,2020-03-03 16:17:07,2020-02-28,LXRX,Tessmer James F,"VP, Finance, Accounting",F - Tax,$2.77,-3902,55862,-7%,"-$10,809",,,,,LXRX
64,D,2020-03-03 16:17:07,2020-02-28,LXRX,Tessmer James F,"VP, Finance, Accounting",M - OptEx,$0.00,16396,55862,+42%,+$0,,,,,LXRX
65,D,2020-03-03 16:16:23,2020-02-28,LXRX,Santini Alexander A,"EVP, CCO",F - Tax,$2.77,-12420,42504,-23%,"-$34,403",,,,,LXRX
66,D,2020-03-03 16:16:23,2020-02-28,LXRX,Santini Alexander A,"EVP, CCO",M - OptEx,$0.00,36263,42504,+581%,+$0,,,,,LXRX
67,D,2020-03-03 16:15:17,2020-02-28,LXRX,Lapuerta Pablo,"EVP, CMO",F - Tax,$2.77,-13305,72639,-15%,"-$36,855",,,,,LXRX
68,D,2020-03-03 16:15:17,2020-02-28,LXRX,Lapuerta Pablo,"EVP, CMO",M - OptEx,$0.00,38846,72639,+115%,+$0,,,,,LXRX
69,D,2020-03-03 16:13:08,2020-02-28,LXRX,Main Alan J,"EVP, Commercial Supply Ops",F - Tax,$2.77,-12759,91560,-12%,"-$35,342",,,,,LXRX
70,D,2020-03-03 16:13:08,2020-02-28,LXRX,Main Alan J,"EVP, Commercial Supply Ops",M - OptEx,$0.00,37252,91560,+69%,+$0,,,,,LXRX
71,D,2020-03-03 16:12:22,2020-02-28,LXRX,Crum Brian T,"VP, GC, Secr.",F - Tax,$2.77,-6940,36237,-16%,"-$19,224",,,,,LXRX
72,D,2020-03-03 16:12:22,2020-02-28,LXRX,Crum Brian T,"VP, GC, Secr.",M - OptEx,$0.00,20252,36237,+127%,+$0,,,,,LXRX
73,D,2020-03-03 16:11:05,2020-02-28,LXRX,Coats Lonnel,"Pres, CEO",F - Tax,$2.77,-45320,298866,-13%,"-$125,536",,,,,LXRX
74,D,2020-03-03 16:11:05,2020-02-28,LXRX,Coats Lonnel,"Pres, CEO",M - OptEx,$0.00,116647,298866,+64%,+$0,,,,,LXRX
75,,2019-09-19 16:28:29,2019-09-18,LXRX,Coats Lonnel,"Pres, CEO",P - Purchase,$3.10,50000,227539,+28%,"+$155,000",,,,,LXRX
76,,2019-09-19 16:26:44,2019-09-18,LXRX,Santini Alexander A,"EVP, CCO",P - Purchase,$3.36,4500,18661,+32%,"+$15,115",,,,,LXRX
77,,2019-09-18 16:39:50,2019-09-17,LXRX,Coats Lonnel,"Pres, CEO",P - Purchase,$3.13,50000,177539,+39%,"+$156,403",,,,,LXRX
78,M,2019-09-17 17:36:06,2019-09-13,LXRX,Debbane Raymond,Dir,P - Purchase,$2.69,103042,4634631,+2%,"+$277,591",,,,,LXRX
79,,2019-09-17 17:33:45,2019-09-13,LXRX,Debbane Raymond,Dir,P - Purchase,$2.40,197473,4531589,+5%,"+$474,760",,,,,LXRX
80,,2019-09-17 17:27:35,2019-09-16,LXRX,Sobecki Christopher J,Dir,P - Purchase,$2.55,25000,137293,+22%,"+$63,718",,,,,LXRX
81,,2019-09-17 17:23:43,2019-09-13,LXRX,Sobecki Christopher J,Dir,P - Purchase,$2.41,99249,112293,+761%,"+$238,750",,,,,LXRX
82,M,2019-08-20 17:02:16,2019-08-16,LXRX,Coats Lonnel,"Pres, CEO",P - Purchase,$1.35,40000,127539,+46%,"+$54,029",,,,,LXRX
83,,2019-08-02 16:15:28,2019-08-02,LXRX,Tessmer James F,"VP, Finance, Accounting",P - Purchase,$1.14,10000,43368,+30%,"+$11,400",,,,,LXRX
84,,2019-08-02 16:12:12,2019-08-02,LXRX,Barker Sam L,Dir,P - Purchase,$1.18,24000,52187,+85%,"+$28,200",,,,,LXRX
85,D,2019-03-01 17:20:45,2019-02-28,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",F - Tax,$5.51,-8639,72508,-11%,"-$47,601",,,,,LXRX
86,D,2019-03-01 17:20:45,2019-02-28,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",M - OptEx,$0.00,22655,72508,+45%,+$0,,,,,LXRX
87,D,2019-03-01 17:19:39,2019-02-28,LXRX,Tyle Praveen,"EVP, R, D",M - OptEx,$0.00,12717,14979,+562%,+$0,,,,,LXRX
88,D,2019-03-01 17:18:53,2019-02-28,LXRX,Tessmer James F,"VP, Finance, Accounting",F - Tax,$5.51,-2501,33368,-7%,"-$13,781",,,,,LXRX
89,D,2019-03-01 17:18:53,2019-02-28,LXRX,Tessmer James F,"VP, Finance, Accounting",M - OptEx,$0.00,10226,33368,+44%,+$0,,,,,LXRX
90,D,2019-03-01 17:18:14,2019-02-28,LXRX,Santini Alexander A,"EVP, CCO",F - Tax,$5.51,-4544,14161,-24%,"-$25,037",,,,,LXRX
91,D,2019-03-01 17:18:14,2019-02-28,LXRX,Santini Alexander A,"EVP, CCO",M - OptEx,$0.00,13408,14161,>999%,+$0,,,,,LXRX
92,D,2019-03-01 17:17:32,2019-02-28,LXRX,Main Alan J,"EVP, Commercial Supply Ops",F - Tax,$5.51,-6885,67067,-9%,"-$37,936",,,,,LXRX
93,D,2019-03-01 17:17:32,2019-02-28,LXRX,Main Alan J,"EVP, Commercial Supply Ops",M - OptEx,$0.00,20151,67067,+43%,+$0,,,,,LXRX
94,D,2019-03-01 17:16:33,2019-02-28,LXRX,Lapuerta Pablo,"EVP, CMO",F - Tax,$5.51,-6809,47098,-13%,"-$37,518",,,,,LXRX
95,D,2019-03-01 17:16:33,2019-02-28,LXRX,Lapuerta Pablo,"EVP, CMO",M - OptEx,$0.00,19932,47098,+73%,+$0,,,,,LXRX
96,D,2019-03-01 17:15:04,2019-02-28,LXRX,Coats Lonnel,"Pres, CEO",F - Tax,$5.51,-18641,87539,-18%,"-$102,712",,,,,LXRX
97,D,2019-03-01 17:15:04,2019-02-28,LXRX,Coats Lonnel,"Pres, CEO",M - OptEx,$0.00,48101,87539,+122%,+$0,,,,,LXRX
98,M,2018-06-29 16:23:25,2018-06-27,LXRX,"Invus Public Equities, L.P.","Dir, 10%",P - Purchase,$12.51,182838,60240864,0%,"+$2,287,377",,,,,LXRX
99,M,2018-06-26 17:32:15,2018-06-22,LXRX,"Invus Public Equities, L.P.","Dir, 10%",P - Purchase,$12.99,253725,60058026,0%,"+$3,295,173",,,,,LXRX
100,M,2018-06-21 17:55:10,2018-06-19,LXRX,"Invus Public Equities, L.P.","Dir, 10%",P - Purchase,$13.29,72973,59804301,0%,"+$970,045",,,,,LXRX
101,M,2018-06-18 18:56:39,2018-06-14,LXRX,"Invus Public Equities, L.P.","Dir, 10%",P - Purchase,$12.98,45784,59731328,0%,"+$594,399",,,,,LXRX
102,M,2018-06-12 18:10:54,2018-06-08,LXRX,"Invus Public Equities, L.P.","Dir, 10%",P - Purchase,$12.80,235396,59685544,0%,"+$3,014,123",,,,,LXRX
103,D,2018-06-12 16:37:38,2018-06-08,LXRX,Tessmer James F,"VP, Finance, Accounting",M - OptEx,$10.15,10000,25643,+64%,"+$101,500",,,,,LXRX
104,D,2018-06-12 16:37:38,2018-06-08,LXRX,Tessmer James F,"VP, Finance, Accounting",S - Sale+OE,$12.91,-10000,25643,-28%,"-$129,076",,,,,LXRX
105,M,2018-06-07 19:37:43,2018-06-05,LXRX,"Invus Public Equities, L.P.","Dir, 10%",P - Purchase,$12.58,325639,59450148,+1%,"+$4,095,065",,,,,LXRX
106,M,2018-06-04 17:31:20,2018-05-31,LXRX,"Invus Public Equities, L.P.","Dir, 10%",P - Purchase,$12.01,416481,59124509,+1%,"+$5,002,667",,,,,LXRX
107,M,2018-05-30 20:53:21,2018-05-25,LXRX,"Invus Public Equities, L.P.","Dir, 10%",P - Purchase,$9.94,433378,58708028,+1%,"+$4,306,418",,,,,LXRX
108,,2018-05-25 16:43:57,2018-05-23,LXRX,Santini Alexander A,"EVP, CCO",P - Purchase,$9.78,745,5297,+16%,"+$7,286",,,,,LXRX
109,D,2018-04-27 17:42:04,2018-04-27,LXRX,Swain Judith L,Dir,A - Grant,$0.00,2564,12902,+25%,+$0,,,,,LXRX
110,D,2018-04-27 17:41:09,2018-04-27,LXRX,Sobecki Christopher J,Dir,A - Grant,$0.00,2564,13044,+24%,+$0,,,,,LXRX
111,D,2018-04-27 17:40:18,2018-04-27,LXRX,Palantoni Frank,Dir,A - Grant,$0.00,2564,12902,+25%,+$0,,,,,LXRX
112,D,2018-04-27 17:39:25,2018-04-27,LXRX,Nies Alan S,Dir,A - Grant,$0.00,2564,13616,+23%,+$0,,,,,LXRX
113,D,2018-04-27 17:38:10,2018-04-27,LXRX,Lefkowitz Robert J Md,Dir,A - Grant,$0.00,2564,12902,+25%,+$0,,,,,LXRX
114,D,2018-04-27 17:37:14,2018-04-27,LXRX,Debbane Raymond,Dir,A - Grant,$0.00,2564,4334116,0%,+$0,,,,,LXRX
115,D,2018-04-27 17:36:21,2018-04-27,LXRX,Barker Sam L,Dir,A - Grant,$0.00,2564,28187,+10%,+$0,,,,,LXRX
116,D,2018-04-27 17:35:07,2018-04-27,LXRX,Amouyal Philippe,Dir,A - Grant,$0.00,2564,12902,+25%,+$0,,,,,LXRX
117,D,2018-03-02 17:12:49,2018-02-28,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",F - Tax,$8.53,-6133,59492,-9%,"-$52,314",,,,,LXRX
118,D,2018-03-02 17:12:49,2018-02-28,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",M - OptEx,$0.00,16028,59492,+37%,+$0,,,,,LXRX
119,D,2018-03-02 17:11:52,2018-02-28,LXRX,Tyle Praveen,"EVP, R, D",F - Tax,$8.53,-728,2262,-24%,"-$6,210",,,,,LXRX
120,D,2018-03-02 17:11:52,2018-02-28,LXRX,Tyle Praveen,"EVP, R, D",M - OptEx,$0.00,2990,2262,-411%,+$0,,,,,LXRX
121,D,2018-03-02 17:11:00,2018-02-28,LXRX,Tessmer James F,"VP, Finance, Accounting",F - Tax,$8.53,-1805,25643,-7%,"-$15,397",,,,,LXRX
122,D,2018-03-02 17:11:00,2018-02-28,LXRX,Tessmer James F,"VP, Finance, Accounting",M - OptEx,$0.00,7353,25643,+40%,+$0,,,,,LXRX
123,D,2018-03-02 17:09:57,2018-02-28,LXRX,Santini Alexander A,"EVP, CCO",F - Tax,$8.53,-1652,4552,-27%,"-$14,092",,,,,LXRX
124,D,2018-03-02 17:09:57,2018-02-28,LXRX,Santini Alexander A,"EVP, CCO",M - OptEx,$0.00,4945,4552,-1258%,+$0,,,,,LXRX
125,D,2018-03-02 17:08:58,2018-02-28,LXRX,Main Alan J,"EVP, Commercial Supply Ops",F - Tax,$8.53,-4962,53801,-8%,"-$42,326",,,,,LXRX
126,D,2018-03-02 17:08:58,2018-02-28,LXRX,Main Alan J,"EVP, Commercial Supply Ops",M - OptEx,$0.00,14533,53801,+37%,+$0,,,,,LXRX
127,D,2018-03-02 17:08:02,2018-02-28,LXRX,Lapuerta Pablo,"EVP, CMO",F - Tax,$8.53,-4822,33975,-12%,"-$41,132",,,,,LXRX
128,D,2018-03-02 17:08:02,2018-02-28,LXRX,Lapuerta Pablo,"EVP, CMO",M - OptEx,$0.00,14184,33975,+72%,+$0,,,,,LXRX
129,D,2018-03-02 17:07:03,2018-02-28,LXRX,Coats Lonnel,"Pres, CEO",F - Tax,$8.53,-9494,58079,-14%,"-$80,984",,,,,LXRX
130,D,2018-03-02 17:07:03,2018-02-28,LXRX,Coats Lonnel,"Pres, CEO",M - OptEx,$0.00,24588,58079,+73%,+$0,,,,,LXRX
131,M,2017-11-17 20:09:56,2017-11-15,LXRX,"Invus Public Equities, L.P.","Dir, 10%",P - Purchase,$10.11,180727,58274650,0%,"+$1,826,896",,,,,LXRX
132,,2017-11-15 17:15:00,2017-11-15,LXRX,Coats Lonnel,"Pres, CEO",P - Purchase,$9.91,10000,42985,+30%,"+$99,100",,,,,LXRX
133,M,2017-11-14 19:32:04,2017-11-10,LXRX,"Invus Public Equities, L.P.","Dir, 10%",P - Purchase,$9.64,575946,58093923,+1%,"+$5,554,166",,,,,LXRX
134,,2017-11-14 18:55:28,2017-11-14,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",P - Purchase,$9.48,2000,50597,+4%,"+$18,962",,,,,LXRX
135,,2017-09-18 06:40:34,2017-09-15,LXRX,Coats Lonnel,"Pres, CEO",P - Purchase,$12.54,30000,32985,>999%,"+$376,337",,,,,LXRX
136,,2017-09-18 06:36:48,2017-09-15,LXRX,Barker Sam L,Dir,P - Purchase,$12.50,1000,25623,+4%,"+$12,500",,,,,LXRX
137,D,2017-05-01 16:54:36,2017-04-28,LXRX,Swain Judith L,Dir,A - Grant,$0.00,1281,10338,+14%,+$0,0.0,2.0,,,LXRX
138,D,2017-05-01 16:53:43,2017-04-28,LXRX,Sobecki Christopher J,Dir,A - Grant,$0.00,1281,10480,+14%,+$0,0.0,2.0,,,LXRX
139,D,2017-05-01 16:52:51,2017-04-28,LXRX,Palantoni Frank,Dir,A - Grant,$0.00,1281,10338,+14%,+$0,0.0,2.0,,,LXRX
140,D,2017-05-01 16:51:55,2017-04-28,LXRX,Nies Alan S,Dir,A - Grant,$0.00,1281,11052,+13%,+$0,0.0,2.0,,,LXRX
141,D,2017-05-01 16:51:00,2017-04-28,LXRX,Lefkowitz Robert J Md,Dir,A - Grant,$0.00,1281,10338,+14%,+$0,0.0,2.0,,,LXRX
142,D,2017-05-01 16:50:07,2017-04-28,LXRX,Debbane Raymond,Dir,A - Grant,$0.00,1281,4331552,0%,+$0,0.0,2.0,,,LXRX
143,D,2017-05-01 16:48:56,2017-04-28,LXRX,Barker Sam L,Dir,A - Grant,$0.00,1281,24623,+5%,+$0,0.0,2.0,,,LXRX
144,D,2017-05-01 16:47:57,2017-04-28,LXRX,Amouyal Philippe,Dir,A - Grant,$0.00,1281,10338,+14%,+$0,0.0,2.0,,,LXRX
145,D,2017-03-01 18:53:29,2017-02-28,LXRX,Tessmer James F,"VP, Finance, Accounting",F - Tax,$16.45,-2790,20095,-12%,"-$45,896",-4.0,2.0,-6.0,,LXRX
146,D,2017-03-01 18:53:29,2017-02-28,LXRX,Tessmer James F,"VP, Finance, Accounting",M - OptEx,$0.00,6939,20095,+53%,+$0,-4.0,2.0,-6.0,,LXRX
147,D,2017-03-01 18:52:28,2017-02-28,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",F - Tax,$16.45,-6455,48597,-12%,"-$106,185",-4.0,2.0,-6.0,,LXRX
148,D,2017-03-01 18:52:28,2017-02-28,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",M - OptEx,$0.00,15659,48597,+48%,+$0,-4.0,2.0,-6.0,,LXRX
149,D,2017-03-01 18:51:10,2017-02-28,LXRX,Santini Alexander A,"EVP, CCO",F - Tax,$16.45,-1093,1259,-46%,"-$17,980",-4.0,2.0,-6.0,,LXRX
150,D,2017-03-01 18:51:10,2017-02-28,LXRX,Santini Alexander A,"EVP, CCO",M - OptEx,$0.00,2352,1259,-215%,+$0,-4.0,2.0,-6.0,,LXRX
151,D,2017-03-01 18:50:15,2017-02-28,LXRX,Main Alan J,"EVP, CMC, Supply Operations",F - Tax,$16.45,-5361,44230,-11%,"-$88,188",-4.0,2.0,-6.0,,LXRX
152,D,2017-03-01 18:50:15,2017-02-28,LXRX,Main Alan J,"EVP, CMC, Supply Operations",M - OptEx,$0.00,14391,44230,+48%,+$0,-4.0,2.0,-6.0,,LXRX
153,D,2017-03-01 18:49:10,2017-02-28,LXRX,Lapuerta Pablo,"EVP, CMO",F - Tax,$16.45,-5252,24613,-18%,"-$86,395",-4.0,2.0,-6.0,,LXRX
154,D,2017-03-01 18:49:10,2017-02-28,LXRX,Lapuerta Pablo,"EVP, CMO",M - OptEx,$0.00,14099,24613,+134%,+$0,-4.0,2.0,-6.0,,LXRX
155,D,2017-03-01 18:48:06,2017-02-28,LXRX,Coats Lonnel,"Pres, CEO",F - Tax,$16.45,-5258,20767,-20%,"-$86,494",-4.0,2.0,-6.0,,LXRX
156,D,2017-03-01 18:48:06,2017-02-28,LXRX,Coats Lonnel,"Pres, CEO",M - OptEx,$0.00,19226,20767,>999%,+$0,-4.0,2.0,-6.0,,LXRX
157,D,2016-06-08 08:22:17,2016-06-06,LXRX,Tessmer James F,"VP, Finance, Accounting",M - OptEx,$6.23,1500,15946,+10%,"+$9,345",1.0,-4.0,1.0,7.0,LXRX
158,D,2016-06-08 08:22:17,2016-06-06,LXRX,Tessmer James F,"VP, Finance, Accounting",S - Sale+OE,$15.00,-1500,15946,-9%,"-$22,500",1.0,-4.0,1.0,7.0,LXRX
159,D,2016-05-23 17:56:16,2016-05-23,LXRX,Tessmer James F,"VP, Finance, Accounting",M - OptEx,$6.23,6000,15946,+60%,"+$37,380",-3.0,2.0,0.0,29.0,LXRX
160,D,2016-05-23 17:56:16,2016-05-23,LXRX,Tessmer James F,"VP, Finance, Accounting",S - Sale+OE,$13.00,-6000,15946,-27%,"-$78,000",-3.0,2.0,0.0,29.0,LXRX
161,D,2016-05-02 17:55:09,2016-04-29,LXRX,Swain Judith L,Dir,A - Grant,$0.00,1432,9057,+19%,+$0,-9.0,-15.0,0.0,7.0,LXRX
162,D,2016-05-02 17:53:50,2016-04-29,LXRX,Sobecki Christopher J,Dir,A - Grant,$0.00,1432,9199,+18%,+$0,-9.0,-15.0,0.0,7.0,LXRX
163,D,2016-05-02 17:52:53,2016-04-29,LXRX,Palantoni Frank,Dir,A - Grant,$0.00,1432,9057,+19%,+$0,-9.0,-15.0,0.0,7.0,LXRX
164,D,2016-05-02 17:51:54,2016-04-29,LXRX,Nies Alan S,Dir,A - Grant,$0.00,1432,9771,+17%,+$0,-9.0,-15.0,0.0,7.0,LXRX
165,D,2016-05-02 17:50:24,2016-04-29,LXRX,Lefkowitz Robert J Md,Dir,A - Grant,$0.00,1432,9057,+19%,+$0,-9.0,-15.0,0.0,7.0,LXRX
166,D,2016-05-02 17:48:44,2016-04-29,LXRX,Debbane Raymond,Dir,A - Grant,$0.00,1432,4330271,0%,+$0,-9.0,-15.0,0.0,7.0,LXRX
167,D,2016-05-02 17:47:33,2016-04-29,LXRX,Barker Sam L,Dir,A - Grant,$0.00,1432,23342,+7%,+$0,-9.0,-15.0,0.0,7.0,LXRX
168,D,2016-05-02 17:43:38,2016-04-29,LXRX,Amouyal Philippe,Dir,A - Grant,$0.00,1432,9057,+19%,+$0,-9.0,-15.0,0.0,7.0,LXRX
169,D,2016-03-02 08:46:52,2016-02-29,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",F - Tax,$9.07,-3815,39393,-9%,"-$34,602",7.0,1.0,10.0,28.0,LXRX
170,D,2016-03-02 08:46:52,2016-02-29,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",M - OptEx,$0.00,13949,39393,+55%,+$0,7.0,1.0,10.0,28.0,LXRX
171,D,2016-03-02 08:46:03,2016-02-29,LXRX,Main Alan J,"EVP, CMC, Supply Operations",F - Tax,$9.07,-4754,35200,-12%,"-$43,119",7.0,1.0,10.0,28.0,LXRX
172,D,2016-03-02 08:46:03,2016-02-29,LXRX,Main Alan J,"EVP, CMC, Supply Operations",M - OptEx,$0.00,12807,35200,+57%,+$0,7.0,1.0,10.0,28.0,LXRX
173,D,2016-03-02 08:45:14,2016-02-29,LXRX,Lapuerta Pablo,"EVP, CMO",F - Tax,$9.07,-4357,15766,-22%,"-$39,518",7.0,1.0,10.0,28.0,LXRX
174,D,2016-03-02 08:45:14,2016-02-29,LXRX,Lapuerta Pablo,"EVP, CMO",M - OptEx,$0.00,11728,15766,+290%,+$0,7.0,1.0,10.0,28.0,LXRX
175,D,2016-03-02 08:44:13,2016-02-29,LXRX,Coats Lonnel,"Pres, CEO",F - Tax,$9.07,-4036,6799,-37%,"-$36,607",7.0,1.0,10.0,28.0,LXRX
176,D,2016-03-02 08:44:13,2016-02-29,LXRX,Coats Lonnel,"Pres, CEO",M - OptEx,$0.00,10835,6799,-268%,+$0,7.0,1.0,10.0,28.0,LXRX
177,D,2016-03-02 08:43:13,2016-02-29,LXRX,Tessmer James F,"VP, Finance, Accounting",F - Tax,$9.07,-1626,15946,-9%,"-$14,748",7.0,1.0,10.0,28.0,LXRX
178,D,2016-03-02 08:43:13,2016-02-29,LXRX,Tessmer James F,"VP, Finance, Accounting",M - OptEx,$0.00,5828,15946,+58%,+$0,7.0,1.0,10.0,28.0,LXRX
179,D,2015-04-24 17:34:40,2015-04-24,LXRX,Debbane Raymond,Dir,A - Grant,$0.00,18691,30301881,0%,+$0,-4.0,-9.0,0.0,40.0,LXRX
180,D,2015-04-24 17:33:09,2015-04-24,LXRX,Sobecki Christopher J,Dir,A - Grant,$0.00,18691,54376,+52%,+$0,-4.0,-9.0,0.0,40.0,LXRX
181,D,2015-04-24 17:31:25,2015-04-24,LXRX,Amouyal Philippe,Dir,A - Grant,$0.00,18691,53376,+54%,+$0,-4.0,-9.0,0.0,40.0,LXRX
182,D,2015-04-24 17:30:17,2015-04-24,LXRX,Swain Judith L,Dir,A - Grant,$0.00,18691,53376,+54%,+$0,-4.0,-9.0,0.0,40.0,LXRX
183,D,2015-04-24 17:29:18,2015-04-24,LXRX,Palantoni Frank,Dir,A - Grant,$0.00,18691,53376,+54%,+$0,-4.0,-9.0,0.0,40.0,LXRX
184,D,2015-04-24 17:25:56,2015-04-24,LXRX,Nies Alan S,Dir,A - Grant,$0.00,18691,58376,+47%,+$0,-4.0,-9.0,0.0,40.0,LXRX
185,D,2015-04-24 17:24:38,2015-04-24,LXRX,Barker Sam L,Dir,A - Grant,$0.00,18691,153376,+14%,+$0,-4.0,-9.0,0.0,40.0,LXRX
186,D,2015-04-24 17:23:33,2015-04-24,LXRX,Lefkowitz Robert J Md,Dir,A - Grant,$0.00,18691,53376,+54%,+$0,-4.0,-9.0,0.0,40.0,LXRX
187,D,2015-03-03 16:11:42,2015-03-02,LXRX,Lapuerta Pablo,"EVP, CMO",F - Tax,$0.94,-18266,58767,-24%,"-$17,170",7.0,20.0,-4.0,88.0,LXRX
188,D,2015-03-03 16:11:42,2015-03-02,LXRX,Lapuerta Pablo,"EVP, CMO",M - OptEx,$0.00,50250,58767,+590%,+$0,7.0,20.0,-4.0,88.0,LXRX
189,D,2015-03-03 16:10:23,2015-03-02,LXRX,Main Alan J,"EVP, CMC, Supply Operations",F - Tax,$0.94,-25318,190032,-12%,"-$23,799",7.0,20.0,-4.0,88.0,LXRX
190,D,2015-03-03 16:10:23,2015-03-02,LXRX,Main Alan J,"EVP, CMC, Supply Operations",M - OptEx,$0.00,69000,190032,+57%,+$0,7.0,20.0,-4.0,88.0,LXRX
191,D,2015-03-03 16:08:14,2015-03-02,LXRX,Northcott John,"VP, Marketing, Comm Strategy",F - Tax,$0.94,-3015,8235,-27%,"-$2,834",7.0,20.0,-4.0,88.0,LXRX
192,D,2015-03-03 16:08:14,2015-03-02,LXRX,Northcott John,"VP, Marketing, Comm Strategy",M - OptEx,$0.00,11250,8235,-373%,+$0,7.0,20.0,-4.0,88.0,LXRX
193,D,2015-03-03 16:06:29,2015-03-02,LXRX,Tessmer James F,"VP, Finance, Accounting",F - Tax,$0.94,-9041,82225,-10%,"-$8,499",7.0,20.0,-4.0,88.0,LXRX
194,D,2015-03-03 16:06:29,2015-03-02,LXRX,Tessmer James F,"VP, Finance, Accounting",M - OptEx,$0.00,29625,82225,+56%,+$0,7.0,20.0,-4.0,88.0,LXRX
195,D,2015-03-03 16:04:52,2015-03-02,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",F - Tax,$0.94,-20718,204821,-9%,"-$19,475",7.0,20.0,-4.0,88.0,LXRX
196,D,2015-03-03 16:04:52,2015-03-02,LXRX,Wade Jeffrey L,"EVP, Corp Adm Affairs, CFO",M - OptEx,$0.00,75750,204821,+59%,+$0,7.0,20.0,-4.0,88.0,LXRX
197,,2014-12-12 19:02:29,2014-12-12,LXRX,Invus C.V.,"Dir, 10%",P - Purchase,$0.88,150000,30283190,0%,"+$132,030",0.0,6.0,18.0,31.0,LXRX
198,,2014-12-10 21:14:05,2014-12-10,LXRX,Invus C.V.,"Dir, 10%",P - Purchase,$0.90,315896,30133190,+1%,"+$285,349",1.0,-3.0,5.0,30.0,LXRX
199,,2014-11-26 19:19:47,2014-11-26,LXRX,Artal International S.C.A.,"Dir, 10%",P - Purchase,$1.01,149253731,402625866,+59%,"+$150,000,000",2.0,-2.0,-9.0,0.0,LXRX
200,D,2014-04-29 16:23:23,2014-04-25,LXRX,Debbane Raymond,Dir,A - Grant,$0.00,12820,29817294,0%,+$0,3.0,0.0,-11.0,-7.0,LXRX
201,D,2014-04-29 16:22:19,2014-04-25,LXRX,Sobecki Christopher J,Dir,A - Grant,$0.00,12820,35685,+56%,+$0,3.0,0.0,-11.0,-7.0,LXRX
202,D,2014-04-29 16:21:27,2014-04-25,LXRX,Debbane Raymond,Dir,A - Grant,$0.00,12820,29817294,0%,+$0,3.0,0.0,-11.0,-7.0,LXRX
203,D,2014-04-29 16:19:17,2014-04-25,LXRX,Amouyal Philippe,Dir,A - Grant,$0.00,12820,34685,+59%,+$0,3.0,0.0,-11.0,-7.0,LXRX
204,D,2014-04-29 16:18:08,2014-04-25,LXRX,Lefkowitz Robert J Md,Dir,A - Grant,$0.00,12820,34685,+59%,+$0,3.0,0.0,-11.0,-7.0,LXRX
205,D,2014-04-29 16:17:14,2014-04-25,LXRX,Barker Sam L,Dir,A - Grant,$0.00,12820,134685,+11%,+$0,3.0,0.0,-11.0,-7.0,LXRX
206,D,2014-04-29 16:15:52,2014-04-25,LXRX,Nies Alan S,Dir,A - Grant,$0.00,12820,39685,+48%,+$0,3.0,0.0,-11.0,-7.0,LXRX
207,D,2014-04-29 16:14:44,2014-04-25,LXRX,Swain Judith L,Dir,A - Grant,$0.00,12820,34685,+59%,+$0,3.0,0.0,-11.0,-7.0,LXRX
208,D,2014-04-29 16:13:47,2014-04-25,LXRX,Palantoni Frank,Dir,A - Grant,$0.00,12820,34685,+59%,+$0,3.0,0.0,-11.0,-7.0,LXRX
209,D,2014-03-03 18:20:20,2014-02-28,LXRX,Sands Arthur T,"Pres, CEO",F - Tax,$1.92,-29791,1898829,-2%,"-$57,199",6.0,2.0,-1.0,-14.0,LXRX
210,D,2014-03-03 18:20:20,2014-02-28,LXRX,Sands Arthur T,"Pres, CEO",M - OptEx,$0.00,108250,1898829,+6%,+$0,6.0,2.0,-1.0,-14.0,LXRX
211,D,2014-03-03 18:19:29,2014-02-28,LXRX,Lapuerta Pablo,"EVP, Clin Dev, CMO",F - Tax,$1.92,-11992,26783,-31%,"-$23,025",6.0,2.0,-1.0,-14.0,LXRX
212,D,2014-03-03 18:19:29,2014-02-28,LXRX,Lapuerta Pablo,"EVP, Clin Dev, CMO",M - OptEx,$0.00,30500,26783,-821%,+$0,6.0,2.0,-1.0,-14.0,LXRX
213,D,2014-03-03 18:18:30,2014-02-28,LXRX,Main Alan J,"EVP, Pharmaceutical Research",F - Tax,$1.92,-18668,146350,-11%,"-$35,843",6.0,2.0,-1.0,-14.0,LXRX
214,D,2014-03-03 18:18:30,2014-02-28,LXRX,Main Alan J,"EVP, Pharmaceutical Research",M - OptEx,$0.00,50250,146350,+52%,+$0,6.0,2.0,-1.0,-14.0,LXRX
215,D,2014-03-03 18:17:34,2014-02-28,LXRX,Tessmer James F,"VP, Finance, Accounting",F - Tax,$1.92,-6612,61641,-10%,"-$12,695",6.0,2.0,-1.0,-14.0,LXRX
216,D,2014-03-03 18:17:34,2014-02-28,LXRX,Tessmer James F,"VP, Finance, Accounting",M - OptEx,$0.00,20250,61641,+49%,+$0,6.0,2.0,-1.0,-14.0,LXRX
217,D,2014-03-03 18:16:40,2014-02-28,LXRX,Zambrowicz Brian P,"EVP, Chief Scientific Officer",F - Tax,$1.92,-18186,278703,-6%,"-$34,917",6.0,2.0,-1.0,-14.0,LXRX
218,D,2014-03-03 18:16:40,2014-02-28,LXRX,Zambrowicz Brian P,"EVP, Chief Scientific Officer",M - OptEx,$0.00,62750,278703,+29%,+$0,6.0,2.0,-1.0,-14.0,LXRX
219,D,2014-03-03 18:15:48,2014-02-28,LXRX,Wade Jeffrey L,"EVP, Corp Dev, CFO",F - Tax,$1.92,-16297,149789,-10%,"-$31,290",6.0,2.0,-1.0,-14.0,LXRX
220,D,2014-03-03 18:15:48,2014-02-28,LXRX,Wade Jeffrey L,"EVP, Corp Dev, CFO",M - OptEx,$0.00,55250,149789,+58%,+$0,6.0,2.0,-1.0,-14.0,LXRX
221,D,2013-05-13 16:59:10,2013-05-10,LXRX,Debbane Raymond,Dir,A - Grant,$0.00,10101,29804474,0%,+$0,2.0,9.0,16.0,11.0,LXRX
222,D,2013-05-13 16:57:41,2013-05-10,LXRX,Barker Sam L,Dir,A - Grant,$0.00,10101,121865,+9%,+$0,2.0,9.0,16.0,11.0,LXRX
223,D,2013-05-13 16:56:20,2013-05-10,LXRX,Swain Judith L,Dir,A - Grant,$0.00,10101,21865,+86%,+$0,2.0,9.0,16.0,11.0,LXRX
224,D,2013-05-13 16:54:45,2013-05-10,LXRX,Sobecki Christopher J,Dir,A - Grant,$0.00,10101,22865,+79%,+$0,2.0,9.0,16.0,11.0,LXRX
225,D,2013-05-13 16:53:15,2013-05-10,LXRX,Nies Alan S,Dir,A - Grant,$0.00,10101,26865,+60%,+$0,2.0,9.0,16.0,11.0,LXRX
226,D,2013-05-13 16:51:41,2013-05-10,LXRX,Palantoni Frank,Dir,A - Grant,$0.00,10101,21865,+86%,+$0,2.0,9.0,16.0,11.0,LXRX
227,D,2013-05-13 16:50:14,2013-05-10,LXRX,Lefkowitz Robert J Md,Dir,A - Grant,$0.00,10101,21865,+86%,+$0,2.0,9.0,16.0,11.0,LXRX
228,D,2013-05-13 16:48:29,2013-05-10,LXRX,Amouyal Philippe,Dir,A - Grant,$0.00,10101,21865,+86%,+$0,2.0,9.0,16.0,11.0,LXRX
229,D,2013-03-01 17:30:52,2013-02-28,LXRX,Main Alan J,"EVP, Pharmaceutical Research",F - Tax,$1.98,-12572,114768,-10%,"-$24,893",-1.0,8.0,10.0,23.0,LXRX
230,D,2013-03-01 17:30:52,2013-02-28,LXRX,Main Alan J,"EVP, Pharmaceutical Research",M - OptEx,$0.00,33750,114768,+42%,+$0,-1.0,8.0,10.0,23.0,LXRX
231,D,2013-03-01 17:29:17,2013-02-28,LXRX,Lapuerta Pablo,"EVP, Clin Dev, CMO",F - Tax,$1.98,-4725,8275,-36%,"-$9,356",-1.0,8.0,10.0,23.0,LXRX
232,D,2013-03-01 17:29:17,2013-02-28,LXRX,Lapuerta Pablo,"EVP, Clin Dev, CMO",M - OptEx,$0.00,13000,8275,-275%,+$0,-1.0,8.0,10.0,23.0,LXRX
233,D,2013-03-01 17:27:52,2013-02-28,LXRX,Sands Arthur T,"Pres, CEO",F - Tax,$1.98,-20034,1820370,-1%,"-$39,667",-1.0,8.0,10.0,23.0,LXRX
234,D,2013-03-01 17:27:52,2013-02-28,LXRX,Sands Arthur T,"Pres, CEO",M - OptEx,$0.00,73250,1820370,+4%,+$0,-1.0,8.0,10.0,23.0,LXRX
235,D,2013-03-01 17:26:10,2013-02-28,LXRX,Tessmer James F,"VP, Finance, Accounting",F - Tax,$1.98,-3807,48003,-7%,"-$7,538",-1.0,8.0,10.0,23.0,LXRX
236,D,2013-03-01 17:26:10,2013-02-28,LXRX,Tessmer James F,"VP, Finance, Accounting",M - OptEx,$0.00,14250,48003,+42%,+$0,-1.0,8.0,10.0,23.0,LXRX
237,D,2013-03-01 17:24:46,2013-02-28,LXRX,Wade Jeffrey L,"EVP, Corp Dev, CFO",F - Tax,$1.98,-10461,110836,-9%,"-$20,713",-1.0,8.0,10.0,23.0,LXRX
238,D,2013-03-01 17:24:46,2013-02-28,LXRX,Wade Jeffrey L,"EVP, Corp Dev, CFO",M - OptEx,$0.00,38250,110836,+53%,+$0,-1.0,8.0,10.0,23.0,LXRX
239,D,2013-03-01 17:22:52,2013-02-28,LXRX,Zambrowicz Brian P,"EVP, Chief Scientific Officer",F - Tax,$1.98,-11692,234139,-5%,"-$23,150",-1.0,8.0,10.0,23.0,LXRX
240,D,2013-03-01 17:22:52,2013-02-28,LXRX,Zambrowicz Brian P,"EVP, Chief Scientific Officer",M - OptEx,$0.00,42750,234139,+22%,+$0,-1.0,8.0,10.0,23.0,LXRX
241,D,2013-02-04 17:04:29,2013-01-31,LXRX,Wade Jeffrey L,"EVP, Corp Dev, CFO",F - Tax,$2.11,-10317,83047,-11%,"-$21,769",3.0,0.0,0.0,18.0,LXRX
242,D,2013-02-04 17:04:29,2013-01-31,LXRX,Wade Jeffrey L,"EVP, Corp Dev, CFO",M - OptEx,$0.00,31600,83047,+61%,+$0,3.0,0.0,0.0,18.0,LXRX
243,D,2013-02-04 17:02:21,2013-01-31,LXRX,Sands Arthur T,"Pres, CEO",F - Tax,$2.11,-21434,1767154,-1%,"-$45,226",3.0,0.0,0.0,18.0,LXRX
244,D,2013-02-04 17:02:21,2013-01-31,LXRX,Sands Arthur T,"Pres, CEO",M - OptEx,$0.00,73700,1767154,+4%,+$0,3.0,0.0,0.0,18.0,LXRX
245,D,2013-02-04 17:00:27,2013-01-31,LXRX,Zambrowicz Brian P,"EVP, Chief Scientific Officer",F - Tax,$2.11,-13499,203081,-6%,"-$28,483",3.0,0.0,0.0,18.0,LXRX
246,D,2013-02-04 17:00:27,2013-01-31,LXRX,Zambrowicz Brian P,"EVP, Chief Scientific Officer",M - OptEx,$0.00,42100,203081,+26%,+$0,3.0,0.0,0.0,18.0,LXRX
247,D,2013-02-04 16:58:48,2013-01-31,LXRX,Main Alan J,"EVP, Pharmaceutical Research",F - Tax,$2.11,-12537,93590,-12%,"-$26,453",3.0,0.0,0.0,18.0,LXRX
248,D,2013-02-04 16:58:48,2013-01-31,LXRX,Main Alan J,"EVP, Pharmaceutical Research",M - OptEx,$0.00,31600,93590,+51%,+$0,3.0,0.0,0.0,18.0,LXRX
249,D,2013-02-04 16:56:59,2013-01-31,LXRX,Tessmer James F,"VP, Finance, Accounting",F - Tax,$2.11,-4310,37560,-10%,"-$9,094",3.0,0.0,0.0,18.0,LXRX
250,D,2013-02-04 16:56:59,2013-01-31,LXRX,Tessmer James F,"VP, Finance, Accounting",M - OptEx,$0.00,13200,37560,+54%,+$0,3.0,0.0,0.0,18.0,LXRX
251,,2012-10-25 17:21:35,2012-10-23,LXRX,"Invus, Cv","Dir, 10%",P - Purchase,$2.25,3000000,283154744,+1%,"+$6,750,000",-4.0,-13.0,-18.0,-9.0,LXRX
252,,2012-10-25 17:21:03,2012-10-23,LXRX,Artal International S.C.A.,"Dir, 10%",P - Purchase,$2.25,3000000,283154744,+1%,"+$6,750,000",-4.0,-13.0,-18.0,-9.0,LXRX
253,AD,2012-05-01 16:23:10,2012-04-27,LXRX,Debbane Raymond,Dir,A - Grant,$0.00,11764,29794373,0%,+$0,2.0,2.0,6.0,36.0,LXRX
254,D,2012-04-27 16:38:01,2012-04-27,LXRX,Swain Judith L,Dir,A - Grant,$0.00,11764,11764,New,+$0,-2.0,-4.0,-3.0,26.0,LXRX
255,D,2012-04-27 16:37:18,2012-04-27,LXRX,Sobecki Christopher J,Dir,A - Grant,$0.00,11764,12764,>999%,+$0,-2.0,-4.0,-3.0,26.0,LXRX
256,D,2012-04-27 16:36:32,2012-04-27,LXRX,Palantoni Frank,Dir,A - Grant,$0.00,11764,11764,New,+$0,-2.0,-4.0,-3.0,26.0,LXRX
257,D,2012-04-27 16:35:38,2012-04-27,LXRX,Nies Alan S,Dir,A - Grant,$0.00,11764,16764,+235%,+$0,-2.0,-4.0,-3.0,26.0,LXRX
258,D,2012-04-27 16:34:48,2012-04-27,LXRX,Lefkowitz Robert J Md,Dir,A - Grant,$0.00,11764,11764,New,+$0,-2.0,-4.0,-3.0,26.0,LXRX
259,D,2012-04-27 16:33:53,2012-04-27,LXRX,Barker Sam L,Dir,A - Grant,$0.00,11764,111764,+12%,+$0,-2.0,-4.0,-3.0,26.0,LXRX
260,D,2012-04-27 16:32:19,2012-04-27,LXRX,Amouyal Philippe,Dir,A - Grant,$0.00,11764,11764,New,+$0,-2.0,-4.0,-3.0,26.0,LXRX
261,D,2012-04-27 16:29:42,2012-04-27,LXRX,Debbane Raymond,"Dir, 10%",A - Grant,$0.00,11764,280166508,0%,+$0,-2.0,-4.0,-3.0,26.0,LXRX
262,D,2012-03-01 16:07:43,2012-02-28,LXRX,Tessmer James F,"VP, Finance, Accounting",F - Tax,$1.78,-2299,28670,-7%,"-$4,092",-7.0,-5.0,11.0,28.0,LXRX
263,D,2012-03-01 16:07:43,2012-02-28,LXRX,Tessmer James F,"VP, Finance, Accounting",M - OptEx,$0.00,7500,28670,+35%,+$0,-7.0,-5.0,11.0,28.0,LXRX
264,D,2012-03-01 16:07:05,2012-02-28,LXRX,Main Alan J,"EVP, Pharmaceutical Research",F - Tax,$1.78,-5907,74527,-7%,"-$10,514",-7.0,-5.0,11.0,28.0,LXRX
265,D,2012-03-01 16:07:05,2012-02-28,LXRX,Main Alan J,"EVP, Pharmaceutical Research",M - OptEx,$0.00,16250,74527,+28%,+$0,-7.0,-5.0,11.0,28.0,LXRX
266,D,2012-03-01 16:06:28,2012-02-28,LXRX,Wade Jeffrey L,"EVP, Corp Dev, CFO",F - Tax,$1.78,-4959,61764,-7%,"-$8,827",-7.0,-5.0,11.0,28.0,LXRX
267,D,2012-03-01 16:06:28,2012-02-28,LXRX,Wade Jeffrey L,"EVP, Corp Dev, CFO",M - OptEx,$0.00,18750,61764,+44%,+$0,-7.0,-5.0,11.0,28.0,LXRX
268,D,2012-03-01 16:05:37,2012-02-28,LXRX,Zambrowicz Brian P,"EVP, Chief Scientific Officer",F - Tax,$1.78,-5621,174480,-3%,"-$10,005",-7.0,-5.0,11.0,28.0,LXRX
269,D,2012-03-01 16:05:37,2012-02-28,LXRX,Zambrowicz Brian P,"EVP, Chief Scientific Officer",M - OptEx,$0.00,21250,174480,+14%,+$0,-7.0,-5.0,11.0,28.0,LXRX
270,D,2012-03-01 16:04:45,2012-02-28,LXRX,Sands Arthur T,"Pres, CEO",F - Tax,$1.78,-9588,1714888,-1%,"-$17,067",-7.0,-5.0,11.0,28.0,LXRX
271,D,2012-03-01 16:04:45,2012-02-28,LXRX,Sands Arthur T,"Pres, CEO",M - OptEx,$0.00,36250,1714888,+2%,+$0,-7.0,-5.0,11.0,28.0,LXRX
272,D,2011-12-27 17:26:00,2011-12-22,LXRX,"Ulys, LLC","Dir, 10%",X - OptEx,$1.13,115004247,5553292,-95%,"$129,954,799",-7.0,2.0,21.0,90.0,LXRX
273,D,2011-12-27 16:12:53,2011-12-22,LXRX,Main Alan J,"EVP, Pharmaceutical Research",M - OptEx,$1.13,19211,64184,+43%,"+$21,708",-7.0,2.0,21.0,90.0,LXRX
274,D,2011-12-27 16:12:06,2011-12-22,LXRX,Barker Sam L,Dir,M - OptEx,$1.13,34000,100000,+52%,"+$38,420",-7.0,2.0,21.0,90.0,LXRX
275,D,2011-12-27 16:10:10,2011-12-22,LXRX,Sands Arthur T,"Pres, CEO",M - OptEx,$1.13,25000,1688226,+2%,"+$28,250",-7.0,2.0,21.0,90.0,LXRX
276,D,2011-02-25 16:41:27,2011-02-23,LXRX,Main Alan J,"EVP, Pharmaceutical Research",A - Grant,$0.00,19337,44973,+75%,+$0,4.0,4.0,-7.0,-30.0,LXRX
277,D,2011-02-25 16:41:27,2011-02-23,LXRX,Main Alan J,"EVP, Pharmaceutical Research",F - Tax,$1.81,-5926,44973,-12%,"-$10,726",4.0,4.0,-7.0,-30.0,LXRX
278,D,2011-02-25 16:40:25,2011-02-23,LXRX,Tessmer James F,"VP, Finance, Accounting",A - Grant,$0.00,6906,23469,+42%,+$0,4.0,4.0,-7.0,-30.0,LXRX
279,D,2011-02-25 16:40:25,2011-02-23,LXRX,Tessmer James F,"VP, Finance, Accounting",F - Tax,$1.81,-2116,23469,-8%,"-$3,830",4.0,4.0,-7.0,-30.0,LXRX
280,D,2011-02-25 16:38:49,2011-02-23,LXRX,Sands Arthur T,"Pres, CEO",A - Grant,$0.00,38674,1663226,+2%,+$0,4.0,4.0,-7.0,-30.0,LXRX
281,D,2011-02-25 16:38:49,2011-02-23,LXRX,Sands Arthur T,"Pres, CEO",F - Tax,$1.81,-10464,1663226,-1%,"-$18,940",4.0,4.0,-7.0,-30.0,LXRX
282,D,2011-02-25 16:37:25,2011-02-23,LXRX,Wade Jeffrey L,"EVP, Corp Dev, CFO",A - Grant,$0.00,19337,47973,+68%,+$0,4.0,4.0,-7.0,-30.0,LXRX
283,D,2011-02-25 16:37:25,2011-02-23,LXRX,Wade Jeffrey L,"EVP, Corp Dev, CFO",F - Tax,$1.81,-5926,47973,-11%,"-$10,726",4.0,4.0,-7.0,-30.0,LXRX
284,D,2011-02-25 16:35:51,2011-02-23,LXRX,Zambrowicz Brian P,"EVP, Chief Scientific Officer",A - Grant,$0.00,26243,158851,+20%,+$0,4.0,4.0,-7.0,-30.0,LXRX
285,D,2011-02-25 16:35:51,2011-02-23,LXRX,Zambrowicz Brian P,"EVP, Chief Scientific Officer",F - Tax,$1.81,-7881,158851,-5%,"-$14,265",4.0,4.0,-7.0,-30.0,LXRX
286,,2010-03-19 17:19:45,2010-03-19,LXRX,"Ulys, LLC",10%,P - Purchase,$1.15,94270206,29782609,-146%,"+$108,410,737",5.0,10.0,19.0,10.0,LXRX
287,D,2010-02-17 18:07:12,2010-02-12,LXRX,Tessmer James F,"VP, Finance, Accounting",F - Tax,$1.91,-3934,18679,-17%,"-$7,514",4.0,3.0,-23.0,-18.0,LXRX
288,D,2010-02-17 17:12:29,2010-02-12,LXRX,Brown Philip M,"SVP, Clinical Development",F - Tax,$1.91,-5632,27306,-17%,"-$10,757",4.0,3.0,-23.0,-18.0,LXRX
289,D,2010-02-17 17:10:04,2010-02-12,LXRX,Main Alan J,"EVP, Pharmaceutical Research",F - Tax,$1.91,-7314,31562,-19%,"-$13,970",4.0,3.0,-23.0,-18.0,LXRX
290,D,2010-02-17 17:08:24,2010-02-12,LXRX,Zambrowicz Brian P,"EVP, Chief Scientific Officer",F - Tax,$1.91,-9011,140489,-6%,"-$17,211",4.0,3.0,-23.0,-18.0,LXRX
291,D,2010-02-17 17:06:37,2010-02-12,LXRX,Wade Jeffrey L,"EVP, GC",F - Tax,$1.91,-7314,34562,-17%,"-$13,970",4.0,3.0,-23.0,-18.0,LXRX
292,D,2010-02-17 17:04:56,2010-02-12,LXRX,Sands Arthur T,"Pres, CEO",F - Tax,$1.91,-14872,1635016,-1%,"-$28,406",4.0,3.0,-23.0,-18.0,LXRX
293,,2009-10-26 16:15:46,2009-10-22,LXRX,Barker Sam L,Dir,P - Purchase,$1.56,19000,66000,+40%,"+$29,672",1.0,-14.0,5.0,-1.0,LXRX
294,M,2009-10-15 16:01:34,2009-10-14,LXRX,"Ulys, LLC",10%,P - Purchase,$1.50,15455145,70840291,+28%,"+$23,182,718",3.0,1.0,-9.0,3.0,LXRX
295,,2009-08-14 16:13:56,2009-08-12,LXRX,Zambrowicz Brian P,"EVP, Chief Scientific Officer",F - Tax,$1.30,-7300,149500,-5%,"-$9,490",-3.0,7.0,22.0,43.0,LXRX
296,,2009-08-14 16:13:53,2009-08-12,LXRX,Wade Jeffrey L,"EVP, Gen. Counsel",F - Tax,$1.30,-5924,41876,-12%,"-$7,701",-3.0,7.0,22.0,43.0,LXRX
297,,2009-08-14 16:13:49,2009-08-12,LXRX,Tessmer James F,"VP, Finance, Acctg",F - Tax,$1.30,-3187,22613,-12%,"-$4,143",-3.0,7.0,22.0,43.0,LXRX
298,,2009-08-14 16:13:47,2009-08-12,LXRX,Sands Arthur T,"Pres, CEO",F - Tax,$1.30,-13674,1649888,-1%,"-$17,776",-3.0,7.0,22.0,43.0,LXRX
299,,2009-08-14 16:13:44,2009-08-12,LXRX,Main Alan J,"EVP, Pharmaceutical Research",F - Tax,$1.30,-5924,38876,-13%,"-$7,701",-3.0,7.0,22.0,43.0,LXRX
300,,2009-08-14 16:13:39,2009-08-12,LXRX,Brown Philip M,SVP Clinical Development,F - Tax,$1.30,-4562,32938,-12%,"-$5,931",-3.0,7.0,22.0,43.0,LXRX
301,D,2009-02-17 16:48:01,2009-02-12,LXRX,Zambrowicz Brian P,"EVP, Chief Scientific Officer",A - Grant,$0.00,55200,156800,+54%,+$0,-7.0,-9.0,-15.0,5.0,LXRX
302,D,2009-02-17 16:47:56,2009-02-12,LXRX,Wade Jeffrey L,"EVP, Gen. Counsel",A - Grant,$0.00,44800,47800,>999%,+$0,-7.0,-9.0,-15.0,5.0,LXRX
303,D,2009-02-17 16:47:54,2009-02-12,LXRX,Tessmer James F,"VP, Finance, Acctg",A - Grant,$0.00,24100,25800,>999%,+$0,-7.0,-9.0,-15.0,5.0,LXRX
304,D,2009-02-17 16:47:49,2009-02-12,LXRX,Sands Arthur T,"Pres, CEO",A - Grant,$0.00,103400,1663562,+7%,+$0,-7.0,-9.0,-15.0,5.0,LXRX
305,D,2009-02-17 16:47:46,2009-02-12,LXRX,Main Alan J,"EVP, Pharmaceutical Research",A - Grant,$0.00,44800,44800,New,+$0,-7.0,-9.0,-15.0,5.0,LXRX
306,D,2009-02-17 16:47:42,2009-02-12,LXRX,Brown Philip M,SVP Clinical Development,A - Grant,$0.00,34500,37500,>999%,+$0,-7.0,-9.0,-15.0,5.0,LXRX
307,,2008-05-02 11:49:45,2008-04-30,LXRX,"Ulys, LLC",10%,P - Purchase,$2.00,669052,55385146,+1%,"+$1,338,104",6.0,-3.0,0.0,-36.0,LXRX
308,,2008-04-22 16:34:50,2008-04-18,LXRX,Barker Sam L,Dir,P - Purchase,$1.96,40000,47000,+571%,"+$78,570",6.0,0.0,4.0,-41.0,LXRX
309,,2007-12-20 16:27:39,2007-12-19,LXRX,Nies Alan S,Dir,P - Purchase,$2.98,5000,5000,New,"+$14,900",-1.0,-2.0,-15.0,-38.0,LXRX
310,E,2007-08-24 15:26:29,2007-08-23,LXRX,"Ulys, LLC",10%,P - Purchase,$4.04,50824986,54716094,>999%,"+$205,473,107",1.0,-1.0,6.0,-38.0,LXRX
311,,2007-06-27 16:34:13,2007-06-26,LXRX,Rose Clayton Stuart,Dir,P - Purchase,$3.19,15000,25000,+150%,"+$47,850",-2.0,2.0,1.0,-4.0,LXRX
312,D,2007-06-21 16:28:32,2007-06-19,LXRX,Ishimoto Lance K,"SVP, Intellectual Property",M - OptEx,$2.50,4000,10200,+65%,"+$10,000",-2.0,-3.0,0.0,-12.0,LXRX
313,,2007-05-17 17:13:13,2007-05-15,LXRX,Piggott James R Phd,SVP of Pharm Bio,S - Sale,$3.40,-1000,0,-100%,"-$3,400",1.0,4.0,-7.0,-4.0,LXRX
314,D,2007-03-30 16:46:12,2007-03-29,LEXG,Sands Arthur T,"Pres, CEO",M - OptEx,$1.67,300000,1560162,+24%,"+$501,000",,,,,LXRX
315,D,2007-03-30 16:46:12,2007-03-29,LEXG,Sands Arthur T,"Pres, CEO",S - Sale+OE,$3.60,-190000,1560162,-11%,"-$684,000",,,,,LXRX
316,D,2007-02-02 17:17:51,2007-02-01,LEXG,Zambrowicz Brian P,"EVP, Research",M - OptEx,$1.67,90000,101600,+776%,"+$150,300",,,,,LXRX
317,D,2007-02-02 17:17:51,2007-02-01,LEXG,Zambrowicz Brian P,"EVP, Research",S - Sale+OE,$3.89,-52300,101600,-34%,"-$203,447",,,,,LXRX
318,,2006-08-31 16:36:21,2006-08-18,LEXG,Mills Barry,Dir,P - Purchase,$3.95,25000,25000,New,"+$98,701",,,,,LXRX
319,M,2006-04-19 16:42:27,2006-04-17,LEXG,Sands Arthur T,"Pres, CEO",S - Sale,$5.11,-15000,1450162,-1%,"-$76,653",,,,,LXRX
320,D,2006-03-24 17:40:21,2006-03-23,LEXG,Piggott James R Phd,SVP of Pharm Bio,M - OptEx,$2.50,30000,1000,-103%,"+$75,000",,,,,LXRX
321,D,2006-03-24 17:40:21,2006-03-23,LEXG,Piggott James R Phd,SVP of Pharm Bio,S - Sale+OE,$5.49,-30000,1000,-97%,"-$164,670",,,,,LXRX
322,M,2006-01-05 17:30:37,2005-12-30,LEXG,Gregory Julia P,"EVP, Corp Dev, CFO",S - Sale,$3.77,-11000,55047,-17%,"-$41,420",,,,,LXRX
323,,2005-10-17 17:52:09,2005-10-13,LEXG,Caskey C Thomas,Dir,P - Purchase,$3.40,1000,6500,+18%,"+$3,400",,,,,LXRX
324,,2005-09-06 17:07:42,2005-09-02,LEXG,Caskey C Thomas,Dir,P - Purchase,$4.61,1000,1684900,0%,"+$4,610",,,,,LXRX
325,D,2005-08-16 16:24:09,2005-08-15,LEXG,Zambrowicz Brian P,"EVP, Research",M - OptEx,$0.22,95000,63900,-305%,"+$20,900",,,,,LXRX
326,D,2005-08-16 16:24:09,2005-08-15,LEXG,Zambrowicz Brian P,"EVP, Research",S - Sale+OE,$4.63,-31100,63900,-33%,"-$144,029",,,,,LXRX
327,D,2005-08-16 16:23:59,2005-08-15,LEXG,Sands Arthur T,"Pres, CEO",M - OptEx,$0.00,682500,1465162,+87%,+$0,,,,,LXRX
328,D,2005-08-16 16:23:59,2005-08-15,LEXG,Sands Arthur T,"Pres, CEO",S - Sale+OE,$4.60,-245700,1465162,-14%,"-$1,131,189",,,,,LXRX
329,,2004-12-29 16:36:15,2004-12-29,LEXG,Gregory Julia P,"EVP, Corp Dev, CFO",G - Gift,$0.00,-2400,66047,+4%,-$0,,,,,LXRX
330,,2004-12-29 16:36:15,2004-12-28,LEXG,Gregory Julia P,"EVP, Corp Dev, CFO",S - Sale,$7.60,-3000,66047,-4%,"-$22,801",,,,,LXRX
331,,2004-12-15 17:06:35,2004-12-14,LEXG,Gregory Julia P,"EVP, Corp Dev, CFO",G - Gift,$0.00,-2000,69047,-3%,-$0,,,,,LXRX
332,D,2004-12-06 16:22:07,2004-12-02,LEXG,Piggott James R Phd,SVP of Pharm,M - OptEx,$2.50,20000,1000,-105%,"+$50,000",,,,,LXRX
333,D,2004-12-06 16:22:07,2004-12-02,LEXG,Piggott James R Phd,SVP of Pharm,S - Sale+OE,$7.07,-20000,1000,-95%,"-$141,440",,,,,LXRX
334,D,2004-08-12 17:14:45,2004-08-10,LEXG,Gregory Julia P,"EVP, Corp Dev, CFO",M - OptEx,$2.50,2000,71047,+3%,"+$5,000",,,,,LXRX
335,M,2004-08-09 16:20:35,2004-08-09,LEXG,Caskey C Thomas,Dir,P - Purchase,$5.31,700,1683900,0%,"+$3,714",,,,,LXRX
336,,2004-08-05 17:08:07,2004-08-04,LEXG,Rose Clayton Stuart,Dir,P - Purchase,$5.85,10000,10000,New,"+$58,523",,,,,LXRX
337,D,2004-05-05 17:44:23,2004-05-03,LEXG,Gregory Julia P,"EVP, Corp Dev, CFO",M - OptEx,$2.50,30000,69047,+77%,"+$75,000",,,,,LXRX
338,D,2004-05-05 17:44:23,2004-05-03,LEXG,Gregory Julia P,"EVP, Corp Dev, CFO",S - Sale+OE,$7.13,-36000,69047,-34%,"-$256,764",,,,,LXRX
339,D,2004-02-25 16:13:19,2004-02-23,LEXG,Riggs Randall B,"SVP, Corp Licensing",M - OptEx,$2.50,37500,15000,-167%,"+$93,750",,,,,LXRX
340,D,2004-02-25 16:13:19,2004-02-23,LEXG,Riggs Randall B,"SVP, Corp Licensing",S - Sale+OE,$6.51,-37500,15000,-71%,"-$244,245",,,,,LXRX
341,DM,2004-01-13 17:01:48,2004-01-09,LEXG,Person Christophe,VP Informatics,M - OptEx,$2.12,27500,0,-100%,"+$58,375",,,,,LXRX
342,DM,2004-01-13 17:01:48,2004-01-09,LEXG,Person Christophe,VP Informatics,S - Sale+OE,$6.70,-27500,0,-100%,"-$184,144",,,,,LXRX
343,D,2004-01-08 17:21:29,2004-01-06,LEXG,Riggs Randall B,"SVP, Corp Licensing",M - OptEx,$2.50,25000,15000,-250%,"+$62,500",,,,,LXRX
344,D,2004-01-08 17:21:29,2004-01-06,LEXG,Riggs Randall B,"SVP, Corp Licensing",S - Sale+OE,$6.43,-25000,15000,-63%,"-$160,750",,,,,LXRX
345,,2004-01-05 18:02:53,2003-12-30,LEXG,Gregory Julia P,"EVP, Corp Dev, CFO",G - Gift,$0.00,-1000,75047,-1%,-$0,,,,,LXRX
346,D,2004-01-05 17:46:29,2003-12-31,LEXG,Gregory Julia P,"EVP, Corp Dev, CFO",G - Gift,$0.00,-1000,76047,-1%,-$0,,,,,LXRX
347,D,2004-01-05 17:46:29,2004-01-02,LEXG,Gregory Julia P,"EVP, Corp Dev, CFO",M - OptEx,$2.50,20000,76047,+36%,"+$50,000",,,,,LXRX
348,D,2004-01-05 17:46:29,2004-01-02,LEXG,Gregory Julia P,"EVP, Corp Dev, CFO",S - Sale+OE,$6.02,-8000,76047,-10%,"-$48,148",,,,,LXRX
349,,2003-12-29 14:30:53,2003-12-26,LEXG,Gregory Julia P,"EVP, Corp Dev, CFO",S - Sale,$5.92,-10000,65047,-13%,"-$59,190",,,,,LXRX
350,D,2003-12-29 14:01:12,2003-12-24,LEXG,Piggott James R Phd,SVP of Pharm,M - OptEx,$2.50,20000,1000,-105%,"+$50,000",,,,,LXRX
351,DM,2003-12-29 14:01:12,2003-12-24,LEXG,Piggott James R Phd,SVP of Pharm,S - Sale+OE,$5.92,-20000,1000,-95%,"-$118,367",,,,,LXRX
